Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cumberland Pharmaceuticals (CPIX) Return on Sales (2016 - 2025)

Cumberland Pharmaceuticals' Return on Sales history spans 16 years, with the latest figure at 0.1% for Q4 2025.

  • For Q4 2025, Return on Sales rose 8.0% year-over-year to 0.1%; the TTM value through Dec 2025 reached 0.06%, up 11.0%, while the annual FY2025 figure was 0.06%, 11.0% up from the prior year.
  • Return on Sales for Q4 2025 was 0.1% at Cumberland Pharmaceuticals, up from 0.24% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.11% in Q1 2025 and bottomed at 0.24% in Q3 2025.
  • The 5-year median for Return on Sales is 0.02% (2023), against an average of 0.04%.
  • The largest annual shift saw Return on Sales decreased -24bps in 2024 before it surged 33bps in 2025.
  • A 5-year view of Return on Sales shows it stood at 0.06% in 2021, then plummeted by -80bps to 0.01% in 2022, then plummeted by -963bps to 0.11% in 2023, then plummeted by -73bps to 0.18% in 2024, then soared by 43bps to 0.1% in 2025.
  • Per Business Quant, the three most recent readings for CPIX's Return on Sales are 0.1% (Q4 2025), 0.24% (Q3 2025), and 0.07% (Q2 2025).